covaxin
-
Covishield vaccine to cost Rs 400 per dose for states, Rs 600 for private hospitals: Serum Institute
Scroll Staff
-
Coronavirus: Covaxin neutralises double mutant strain, other variants, says ICMR
Scroll Staff
-
Tamil actor Vivekh dies in Chennai at 59
Scroll Staff
-
Tamil actor Vivekh hospitalised after suffering from cardiac arrest
Scroll Staff
-
Coronavirus: Haffkine Biopharma to produce Covaxin after Centre grants approval to Maharashtra
Scroll Staff
-
Coronavirus: 320 doses of Covaxin missing from Jaipur hospital, FIR filed
Scroll Staff
-
Covid-19: At the current pace, India will need another 13 months to vaccinate 60% of the population
Shreya Raman, IndiaSpend.com Kriti Kapur, IndiaSpend.com
-
India is producing less than half of the 1 crore Covid-19 vaccine doses it needs every day
Govindraj Ethiraj, IndiaSpend.com
-
Should the government open up Covid-19 vaccinations for all?
Vijayta Lalwani Arunabh Saikia
-
Coronavirus: Centre’s expert panel allows clinical trials of third dose of Covaxin
Scroll Staff
-
Brazil refuses permission to import Covaxin, Bharat Biotech says it will fulfil requirements
Scroll Staff
-
The big news: Mamata Banerjee appeals for peace after attack on her, and nine other top stories
Scroll Staff
-
A stark class divide is emerging in India’s Covid-19 vaccination drive
Vijayta Lalwani
-
Bharat Biotech’s Covaxin can drop ‘clinical trial mode’ tag, no consent form needed anymore
Scroll Staff
-
India is widening its Covid-19 vaccination drive, but without sharing data on adverse reactions
Anoo Bhuyan, IndiaSpend.com
-
Disclose your capacity to manufacture Covid vaccines, Delhi HC tells Serum Institute, Bharat Biotech
Scroll Staff
-
The big news: Bharat Biotech vaccine shows 81% efficacy in phase 3 trials, and 9 other top stories
Scroll Staff
-
Covaxin showed 81% efficacy in third phase trials, says Bharat Biotech
Scroll Staff
-
Indians who are waiting for a ‘better’ Covid-19 vaccine might be making a lethal mistake
Manavi Kapur, qz.com
-
When it comes to giving approval, India has different yardsticks for homegrown and foreign vaccines
Manavi Kapur, qz.com